MONOCLONAL ANTIBODIES

Abyntek counts on an international scientific and technical team with extensive experience in the development of monoclonal antibodies by hybridoma technology. The advantages of our services include:

• Feasibility study
• Personalized advice
• Immunization and antibody development strategy planning based on each customer´s needs